3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
48
Prostatic Neoplasms, Castration-Resistant
3
Adenocarcinoma
3
Urogenital Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Diseases
2
Non-metastatic Castration-resistant Prostate Cancer
2
Neoplasms
2
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Metastatic Castration-resistant Prostate Cancer
2
Male Urogenital Diseases
2
Bulbo-Spinal Atrophy, X-Linked
2
Biochemically Recurrent Prostate Cancer
2
Urogenital Diseases
1
Triple Negative Breast Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Refractory or Relapsed Solid Tumors
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
High-Risk Localized Prostate Cancer
1
Granulosa cell tumor of the ovary
1
Genital Diseases, Male
1
Fatigue
1
Depression
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Interventions
Exercise
5
Cognitive Behavioral Therapy
4
Surveys and Questionnaires
3
Educational Status
3
Therapeutics
2
Palliative Care
2
Methylphenidate
2
Dexamethasone
2
Counseling
2
Control Groups
2
Calcium Dobesilate
2
Acupressure
2
Acceptance and Commitment Therapy
2
pegfilgrastim
1
enzalutamide
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
darolutamide
1
auricularum
1
apalutamide
1
Therapeutic Touch
1
Testosterone
1
Surgical Procedures, Operative
1
Sugars
1
Standard of Care
1
Sildenafil Citrate
1
Self-Help Groups
1
Relaxation Therapy
1
Radiotherapy
1
Quality of Life
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fatigue
×
darolutamide
×
1 year
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled